In this issue, Ryan and colleagues describe the preclinical development of a pan-RAF:MEK molecular glue with superior efficacy, brain penetrance, and tolerability in xenograft models of Ras/Raf/MAPK pathway-driven tumors. See related article by Ryan et al., p. 1190 (1).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/2159-8290.CD-24-0539 | DOI Listing |
Publication Analysis
Top Keywords
pan-rafmek molecular
8
molecular glues
4
glues center
4
center stage
4
stage issue
4
issue ryan
4
ryan colleagues
4
colleagues describe
4
describe preclinical
4
preclinical development
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!